Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03754179
Title Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma (COMBI-R2)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Universitair Ziekenhuis Brussel
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL

Additional content available in CKB BOOST